A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions
- 31 March 2011
- journal article
- Published by Elsevier BV in Molecular and Cellular Neuroscience
- Vol. 46 (3), 597-606
- https://doi.org/10.1016/j.mcn.2010.12.011
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Genome-wide association study reveals genetic risk underlying Parkinson's diseaseNature Genetics, 2009
- Microtubule Depolymerization Suppresses α-Synuclein Accumulation in a Mouse Model of Multiple System AtrophyThe American Journal of Pathology, 2009
- α-Synuclein and neuronal cell deathMolecular Neurodegeneration, 2009
- Genomewide association study for susceptibility genes contributing to familial Parkinson diseaseHuman Genetics, 2008
- Olfactory deficits in mice overexpressing human wildtype α‐synucleinEuropean Journal of Neuroscience, 2008
- Abnormal colonic motility in mice overexpressing human wild-type α-synucleinNeuroReport, 2008
- Impairment of microtubule system increases α-synuclein aggregation and toxicityBiochemical and Biophysical Research Communications, 2008
- Behavioral and histopathological consequences of paraquat intoxication in mice: Effects of α‐synuclein over‐expressionSynapse, 2007
- Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype α-synucleinNeuroscience, 2006
- α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's ModelsScience, 2006